2023-2024 Kevan Shokat University of California, San Francisco I. Drugging Undruggable Targets in Oncology II. Leveraging Tumor Suppressors and the Immune System to Attack Cancer |
|
2022-2023 Scott Miller Yale University I. Searching for Selective Catalytic Reactions in Complex Molecular Environments II. Peptide-Based Catalysis [2.0] |
|
2021-2022 |
|
2020-2021 (No Lecture) |
|
2019-2020 Erick M. Carreira ETH Zurich I. Advances in Catalysis II. Surprises and Discoveries in Chemistry and Biology with Natural Products |
|
2018-19 I. Functional Materials from Bicyclic Bridged Building Blocks |
|
2017-18 I. Activity-Based Proteomics-Protein Discovery on a Global Scale |
|
2016-17 I. Photoredox Catalysis in Organic Chemistry |
|
2015-16 I. Asymmetric Aminocatalysis |
|
2014-15 I. Bioorthogonal Chemistry: An Enabling Tool for Biology and Drug Development |
|
2013-14 I. Redesign of Vancomycin for Resistant Bacteria |
|
2012-13 I. Theory and Mechanisms of Cycloadditions - Applications in Synthesis, Chemical Biology, and Materials Chemistry |
|
2011-12 Paul A. Wender Stanford University |
|
2010-11 Andrew G. Myers Harvard University |
|
2009-10 Jean M.J. Frechet University of California, Berkeley |
|
2008-09 Peter G. Schultz Scripps Research Institute |
|
2007-08 K.C. Nicolaou Scripps Research Institute |
|
2006-07 K. Barry Sharpless Scripps Research Institute |
|
2005-06 Barbara Imperiali Massachusetts Institute of Technology |
|
2004-05 Ben L. Feringa University of Gronigen |
|
2003-04 Eric N. Jacobsen Harvard University |
|
2002-03 Peter B. Dervan California Institute of Technology |
|
2001-02 Steven V. Ley University of Cambridge |
View a complete list of C. S. Marvel Lecturers.